Showing results (1001-1010 of 1,224) with videos related to
Sort By:
Pageof 123
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 20, 2014
Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem cell transplants in patients with multiple myeloma: a phase II studyThomas Bechtel, Ali McBride, Brooke Crawford, et al.Journal of Synchrotron Radiation|February 28, 2015
Registration of the rotation axis in X-ray tomographyYimeng Yang, Feifei Yang, Ferdinand F Hingerl, et al.Biorxiv : the Preprint Server for Biology|December 19, 2025
Bcl-2 protein Noxa is required for metabolic reprogramming to glutamine dependence and for apoptosis in stimulated human CD8 + T cellsTingyuan Yang, Himani Sharma, Jenna M Benson, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|June 1, 1985
New approaches for the evaluation of pulmonary toxicity: bronchoalveolar lavage fluid analysisR F Henderson, J M Benson, F F Hahn, et al.Frontiers in Oncology|March 4, 2021
Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma PatientsFrancesca Cottini, Ying Huang, Nita Williams, et al.Cancer Immunology, Immunotherapy : CII|January 15, 2008
Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assaySri Vidya Kondadasula, Kimberly A Varker, Gregory B Lesinski, et al.Journal of Orthopaedic Trauma|January 23, 2024
The Impact of Smoking on Hospital Course and Postoperative Outcomes in Patients With Fracture-Related InfectionsEvan G Gross, Zuhair Mohammed, Karen J Carter, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999
Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitisJ M Benson, S S Stuckman, K L Cox, et al.Blood|May 10, 2017
A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myelomaThomas Martin, Rachid Baz, Don M Benson, et al.Blood|December 9, 2008
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cellsDon M Benson, Jianhua Yu, Brian Becknell, et al.Pageof 123